Lymphoma biology & heterogeneity
Investigating molecular differences between lymphomas through genomic profiling and computational analysis.
UNIVERSITY HOSPITAL ESSEN
The Alig Lab.
Liquid biopsy and precision medicine in lymphoma.
We study lymphoma biology and develop circulating tumor DNA technologies to characterize disease, monitor treatment response, and investigate resistance.
Department of Hematology and
Stem Cell Transplantation · Essen, Germany
LIQUID BIOPSY
Liquid biopsy & molecular monitoring
Developing sensitive approaches to characterize lymphoma and assess molecular changes during treatment.
Treatment resistance & clonal evolution
Studying clonal evolution and mechanisms associated with treatment resistance using genomic analysis and functional models.
PUBLICATIONS
Selected work
Journal of Clinical Oncology2025
Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma
Roschewski et al.
Read publicationNature2024
Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling
Alig*, Esfahani*, Garofalo*, Li* et al.
Read publicationTHE LAB
Clinicians and researchers
working together.
Our team combines clinical, experimental, and computational expertise in lymphoma research.
Meet the full team
FUNDING & RESEARCH NETWORKS
CONTACT
Research enquiries
and collaborations
Interested in our research or potential research opportunities?
Contact Stefan Alig.